
ABOUT

"My expertise is grounded in years of translational and clinical research in immunology and oncology".
Dr Carlos contributes to strategic forums advancing clinical development and biomarker science across America, the UK, and Europe. He has experience presenting data, guiding decisions in governance meetings, disease-focused committees, and drug development boards, supporting pharmaceutical teams and medical science liaisons in shaping biomarker-driven trials, defining inclusion criteria, and aligning translational research with clinical and commercial strategies.


COLLABORATIONS
As part of his commitment to sharing knowledge, Dr. Carlos has a solid collaboration network with KOLs, researchers and mentors, from medical centers in the UK, US and EU, contributing to the advancement of science, innovation and patient care.









